Janumet

Janumet is a prescription medication used to treat type 2 diabetes. It is a combination of two active ingredients: sitagliptin and metformin. Sitagliptin belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing the levels of incretin hormones in the body. These hormones help to lower blood sugar levels. Metformin is a biguanide that works by decreasing the amount of glucose produced by the liver and improving the sensitivity of the body's cells to insulin.

Janumet is typically prescribed when diet and exercise alone are not sufficient to control blood sugar levels, or when a patient is already taking sitagliptin and metformin separately and a combination tablet is desired. It is taken orally, usually once or twice a day with meals. The dosage of Janumet is determined by a healthcare professional based on the individual patient's condition and response to treatment.

Common side effects of Janumet can include diarrhea, nausea, vomiting, and stomach pain. More serious side effects, though less common, can include lactic acidosis (a rare but serious condition associated with metformin), pancreatitis, and severe allergic reactions. It is important for patients to discuss their complete medical history, including kidney problems, liver disease, and heart failure, with their doctor before starting Janumet. Janumet is not intended for use in patients with type 1 diabetes or diabetic ketoacidosis.